A detailed history of Counterweight Ventures, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Counterweight Ventures, LLC holds 22,458 shares of MRK stock, worth $2.03 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares
22,458
Previous 22,107 1.59%
Holding current value
$2.03 Million
Previous $2.51 Billion 11.01%
% of portfolio
1.58%
Previous 1.78%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

BUY
$96.31 - $114.76 $33,804 - $40,280
351 Added 1.59%
22,458 $2.23 Billion
Q3 2024

Nov 08, 2024

BUY
$111.15 - $128.97 $173,171 - $200,935
1,558 Added 7.58%
22,107 $2.51 Billion
Q2 2024

Aug 06, 2024

BUY
$123.8 - $132.96 $31,073 - $33,372
251 Added 1.24%
20,549 $2.54 Billion
Q1 2024

May 01, 2024

SELL
$113.24 - $131.95 $57,752 - $67,294
-510 Reduced 2.45%
20,298 $2.68 Billion
Q4 2023

Feb 27, 2024

BUY
$100.18 - $109.02 $2.08 Million - $2.27 Million
20,808 New
20,808 $2.27 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $229B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Counterweight Ventures, LLC Portfolio

Follow Counterweight Ventures, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Counterweight Ventures, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Counterweight Ventures, LLC with notifications on news.